<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna, Inc. (NASDAQ: MRNA) shares appear to be going from strength to strength, and the premarket price action Tuesday suggests a positive open for the fifth straight session. What Happened: Cambridge, Massachusetts-based Moderna said Japan’s Ministry of Health, Labor and Welfare and its Japanese partner Takeda Pharmaceutical Company Limited (NYSE: TAK) have agreed to purchase an additional 50 million doses of its COVID-19 vaccine and its updated variant booster vaccine candidate, contingent on authorization for the latter.
...read full article on Benzinga
